中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

7 records (took 0.027 seconds)

    Glaucoma treatment
    1.
    发明公开
    Glaucoma treatment 失效
    青光眼治疗

    公开(公告)号：EP0311012A3

    公开(公告)日：1990-07-11

    申请号：EP88116399.2

    申请日：1988-10-04

    Applicant: ABBOTT LABORATORIES

    Inventor： Stein, Herman H. ,  Crowley, Steven R. ,  Plattner, Jacob J.

    IPC: A61K38/07

    CPC classification number: A61K38/553 ,  Y10S514/913 ,  Y10S530/86

    Abstract: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula:
    wherein A is a substituent; W is CO or CHOH and U is CH₂ or NR₂ wherein R₂ is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH₂; R₁ is loweralkyl, cycloalkyl, benzyl, (alpha,­alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, phenethyl, 1-benzyloxyethyl, phenoxy, thiophenoxy or anilino; R₃ is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)alkyl, carboxyalkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R₄ is a substituted amino group; or pharmaceutically acceptable salts or esters thereof. Also disclosed are compositions, methods and kits for treating glaucoma or reducing and/or controlling intraocular pressure wherein the renin inhibiting compound is administered in combination with a beta-adrenergic antagonist, a steroidal antiinflammatory agent or an angiotensin converting enzyme inhibiting compound.

    Abstract translation: 用于治疗或减少和/或控制眼内压的方法和组合物，其包括施用有效量的下式的肾素抑制化合物：其中A是取代基; W是CO或CHOH，U是CH 2或NR 2，其中R 2是氢或低级烷基; 条件是当W是CHOH时，则U是CH 2; R 1是低级烷基，环烷基，苄基，（α，α-）二甲基苄基，4-羟基苄基，4-甲氧基苄基，卤代苄基，（1-萘基）甲基，（2-萘基）甲基，（4-咪唑基）甲基，苯乙基， 苄氧基乙基，苯氧基，硫代苯氧基或苯胺基; 低级链烯基，（（烷氧基）烷氧基）烷基，羧基烷基，（硫代烷氧基）烷基，苄基或杂环取代的甲基; 并且R 4是取代的氨基; 或其药学上可接受的盐或酯。 还公开了用于治疗青光眼或降低和/或控制眼内压的组合物，方法和试剂盒，其中肾素抑制化合物与β-肾上腺素能拮抗剂，甾体抗炎剂或血管紧张素转化酶抑制化合物组合施用。

    Glaucoma treatment
    7.
    发明公开
    Glaucoma treatment 失效
    Behandlung von Glaukom。

    公开(公告)号：EP0311012A2

    公开(公告)日：1989-04-12

    申请号：EP88116399.2

    申请日：1988-10-04

    Applicant: ABBOTT LABORATORIES

    Inventor： Stein, Herman H. ,  Crowley, Steven R. ,  Plattner, Jacob J.

    IPC: A61K38/07

    CPC classification number: A61K38/553 ,  Y10S514/913 ,  Y10S530/86

    Abstract: A method and a composition for treating or reducing and/or controlling intraocular pressure comprising administering an effective amount of a renin inhibiting compound of the formula:
    wherein A is a substituent; W is CO or CHOH and U is CH₂ or NR₂ wherein R₂ is hydrogen or loweralkyl; with the proviso that when W is CHOH then U is CH₂; R₁ is loweralkyl, cycloalkyl, benzyl, (alpha,­alpha)-dimethylbenzyl, 4-hydroxybenzyl, 4-methoxybenzyl, halobenzyl, (1-naphthyl)methyl, (2-naphthyl)methyl, (4-imidazoyl)methyl, phenethyl, 1-benzyloxyethyl, phenoxy, thiophenoxy or anilino; R₃ is loweralkyl, loweralkenyl, ((alkoxy)alkoxy)alkyl, carboxyalkyl, (thioalkoxy)alkyl, benzyl or heterocyclic ring substituted methyl; and R₄ is a substituted amino group; or pharmaceutically acceptable salts or esters thereof.
    Also disclosed are compositions, methods and kits for treating glaucoma or reducing and/or controlling intraocular pressure wherein the renin inhibiting compound is administered in combination with a beta-adrenergic antagonist, a steroidal antiinflammatory agent or an angiotensin converting enzyme inhibiting compound.

    Abstract translation: 一种用于治疗或减少和/或控制眼内压的方法和组合物，包括给予有效量的下列化学式的肾素抑制化合物：其中A是取代基的 W是CO或CHOH，U是CH 2或NR 2，其中R 2是氢或低级烷基; 条件是当W是CHOH时，则U是CH 2; R1是低级烷基，环烷基，苄基，（α，α） - 二甲基苄基，4-羟基苄基，4-甲氧基苄基，卤代苄基，（1-萘基）甲基，（2-萘基）甲基，（4-咪唑基）甲基，苯乙基 苄氧基乙基，苯氧基，硫代苯氧基或苯胺基; R3是低级烷基，低级烯基，（（烷氧基）烷氧基）烷基，羧基烷基，（硫代烷氧基）烷基，苄基或杂环取代的甲基; R4为取代氨基; 或其药学上可接受的盐或酯。 还公开了用于治疗青光眼或降低和/或控制眼内压的组合物，方法和试剂盒，其中肾素抑制化合物与β-肾上腺素能拮抗剂，甾族抗炎药或血管紧张素转化酶抑制化合物联合施用。

Patent Agency Ranking